Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature.


Journal

Cardiovascular revascularization medicine : including molecular interventions
ISSN: 1878-0938
Titre abrégé: Cardiovasc Revasc Med
Pays: United States
ID NLM: 101238551

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 02 01 2019
revised: 05 02 2019
accepted: 19 02 2019
pubmed: 25 3 2019
medline: 28 7 2020
entrez: 26 3 2019
Statut: ppublish

Résumé

Mitral stenosis is a rare and potentially severe complication of transcatheter aortic valve replacement (TAVR). Given the anatomic coupling and interdependence of the aortic and mitral valves, it comes by itself that procedures (either surgical or percutaneous) involving the aortic valve imply the risk of altering mitral valve function. Indeed, transcatheter aortic prostheses may impair adequate anterior mitral leaflet (AML) opening, especially when implanted in a "low" position, thus resulting in high transvalvular gradients. Hereby, we report the case of a 71-year-old male with symptomatic severe aortic stenosis and a history of previous surgical mitral valve repair who underwent TAVR with a self-expandable prosthesis. Notwithstanding an acceptable angiographic position, the prosthetic frame was shown to interfere with the AML, as evidenced by augmented transmitral gradients; nonetheless, pulmonary artery pressures remained unchanged, and the patient experienced symptomatic improvement. Therefore, a conservative approach was chosen and the patient was discharged home after medical therapy optimization. Moreover, we provide a review of the available literature regarding the incidence, predictors and possible management of this infrequent complication.

Identifiants

pubmed: 30905659
pii: S1553-8389(19)30156-3
doi: 10.1016/j.carrev.2019.02.023
pii:
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1196-1202

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Francesco Cannata (F)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Damiano Regazzoli (D)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy. Electronic address: damiano.regazzolilancini@humanitas.it.

Giancarlo Barberis (G)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Mauro Chiarito (M)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Pier Pasquale Leone (PP)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Vincenzo Lavanco (V)

Non-invasive Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Giulio G Stefanini (GG)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Giuseppe Ferrante (G)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Paolo Pagnotta (P)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Renato Bragato (R)

Non-invasive Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Elena Corrada (E)

Non-invasive Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Lucia Torracca (L)

Cardiac Surgery, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Gianluigi Condorelli (G)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Bernhard Reimers (B)

Interventional Cardiology Unit, Cardio Center, Humanitas Research Hospital, Rozzano-Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH